3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
1
Interventions
Irinotecan
2
tivozanib
1
repotrectinib
1
belinostat
1
atezolizumab
1
Topotecan
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
IFL protocol
1
Fluorouracil
1
Etoposide
1
Cisplatin
1
Biopsy
1
BAY 1895344
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Neuroendocrine
×
Octreotide
×
30 days
×
Clear all
No trials found.